I 

117TH CONGRESS 

1ST SESSION H. R. 2636 

To direct the Secretary of Health and Human Services to submit to Congress 

a report on the security and resilience of the United States medical 

supply chains, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

APRIL 16, 2021 

Mr. TRONE (for himself and Mr. JOYCE of Pennsylvania) introduced the 

following bill; which was referred to the Committee on Energy and Commerce 

A BILL 

To direct the Secretary of Health and Human Services to 

submit to Congress a report on the security and resilience of the United States medical supply chains, and 

for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Strengthening our 

5 Health Security Through Resilient Medical Supply Chains 

6 Annual Review Act of 2021’’. 


pbinns on DSKJLVW7X2PROD with BILLS
2 

•HR 2636 IH

1 SEC. 2. REPORT ON SECURITY AND RESILIENCE OF THE 

2 UNITED STATES MEDICAL SUPPLY CHAINS. 

3 (a) IN GENERAL.—Not later than one year after the 

4 date of the enactment of this Act, and annually thereafter, 

5 the Secretary of Health and Human Services shall submit 

6 to the Committee on Energy and Commerce of the House 

7 of Representatives, and the Committee on Health, Edu8 cation, Labor and Pensions of the Senate a report on the 

9 security and resilience of the United States medical supply 

10 chains. Such a report shall contain a classified annex. 

11 (b) PUBLIC AVAILABILITY.—The Secretary shall— 

12 (1) make publicly available (including by publi13 cation on the website of the Department of Health 

14 and Human Services) the unclassified portion of the 

15 report under subsection (a); and 

16 (2) make every reasonable effort to protect 

17 trade secret information and commercially confiden18 tial information. 

19 (c) CONTENTS.—The report submitted under sub20 section (a) shall— 

21 (1) review the United States supply chains for 

22 medical devices, supplies, and drugs and the vulner23 ability of such supply chains to a global disruption, 

24 such as an instance of bioterrorism, a natural dis25 aster, or a public health emergency; 


pbinns on DSKJLVW7X2PROD with BILLS
3 

•HR 2636 IH

1 (2) assess the dependence of the United States 

2 on any medical devices, equipment, supplies, coun3 termeasures, vaccines, and drugs produced or 

4 sourced outside the United States; 

5 (3) identify the actions the Federal government 

6 has taken during the year covered by the report— 

7 (A) to promote the security and resilience 

8 of the United States medical supply chain; 

9 (B) to improve medical supply chain re10 dundancy; 

11 (C) to encourage the domestic production 

12 of medical devices, equipment, supplies, coun13 termeasures, vaccines, and drugs; and 

14 (D) to develop contingency plans for poten15 tial global disruptions; and 

16 (4) provide recommendations to agencies of the 

17 Federal Government, States, local, tribal, and terri18 torial governments, and the private sector on ways 

19 to strengthen the security and resilience of the 

20 United States medical supply chain. 

21 (d) CONSULTATION.—In preparing the report under 

22 subsection (a), the Secretary of Health and Human Serv23 ices— 

24 (1) shall consult with the heads of other rel25 evant Federal agencies; and 


pbinns on DSKJLVW7X2PROD with BILLS
4 

•HR 2636 IH

1 (2) may consult with public health experts, 

2 health security experts, supply chain experts, and 

3 other individuals with relevant experience. 

Æ 


pbinns on DSKJLVW7X2PROD with BILLS